Technical Analysis for CRL - Charles River Laboratories International, Inc.

Grade Last Price % Change Price Change
grade A 221.6 1.74% 3.80
CRL closed up 1.74 percent on Friday, August 7, 2020, on 1.28 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CRL trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 1.74%
Upper Bollinger Band Walk Strength 1.74%
Earnings Movers Other 1.74%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates in two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment is involved in the production and sale of research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, research animal diagnostic services, endotoxin and microbial detection products and services, and avian vaccine products and services. The PCS segment provides preclinical services, including both in vivo and in vitro studies, supportive laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Biotechnology Life Sciences Pharmaceutical Pharmaceutical Industry Drug Discovery Program Management Pharmacokinetics Contract Research Organizations Pre Clinical Development Drug Metabolism

Is CRL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 221.64
52 Week Low 95.58
Average Volume 393,977
200-Day Moving Average 156.90
50-Day Moving Average 187.28
20-Day Moving Average 199.98
10-Day Moving Average 206.60
Average True Range 6.43
ADX 42.1
+DI 35.45
-DI 7.54
Chandelier Exit (Long, 3 ATRs ) 202.36
Chandelier Exit (Short, 3 ATRs ) 198.85
Upper Bollinger Band 219.65
Lower Bollinger Band 180.30
Percent B (%b) 1.05
BandWidth 19.68
MACD Line 8.90
MACD Signal Line 7.06
MACD Histogram 1.8399
Fundamentals Value
Market Cap 10.55 Billion
Num Shares 47.6 Million
EPS 3.80
Price-to-Earnings (P/E) Ratio 58.32
Price-to-Sales 3.11
Price-to-Book 5.83
PEG Ratio 2.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 230.50
Resistance 3 (R3) 229.52 225.58 229.01
Resistance 2 (R2) 225.58 223.31 226.07 228.52
Resistance 1 (R1) 223.59 221.92 224.59 224.57 228.02
Pivot Point 219.65 219.65 220.15 220.14 219.65
Support 1 (S1) 217.66 217.38 218.66 218.64 215.18
Support 2 (S2) 213.72 215.99 214.21 214.68
Support 3 (S3) 211.73 213.72 214.19
Support 4 (S4) 212.71